Potassium Phosphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 12 USDMF, 1 CEP/COS, 8 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers, 70 FDA Orange Book, 15 Europe, 12 Canada, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML), SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML), SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 8 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 4 DKSH, 1 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 28 BASF, 1 Bioplus Life Sciences, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 39 Roquette, 8 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

99 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 42 Direct Compression, 33 Thickeners and Stabilizers, 30 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 30 Taste Masking, 29 Parenteral, 29 Topical, 26 Granulation, 22 Solubilizers, 21 Lubricants & Glidants, 20 Co-Processed Excipients, 19 Chewable & Orodispersible Aids, 19 Film Formers & Plasticizers, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 15 Finished Drug Prices

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 3 US Exclusivities

REF. STANDARDS & IMPURITIES

1 USP

1 USP

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 212832 / DOSAGE - SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Potassium Phosphate, Dibasic(UNII: CI71S98N1Z) (Phosphate Ion - UNII:NK08V8K8HR)	Potassium Phosphate, Dibasic	236mg in 1 \| 236mg in 1 \| 236mg in 1
Potassium Phosphate, Monobasic(UNII: 4J9FJ0HL51) (Phosphate Ion - UNII:NK08V8K8HR)	Potassium Phosphate, Monobasic	224mg in 1 \| 224mg in 1 \| 224mg in 1

Inactive Ingredients

Ingredient Name	Fresenius Kabi USA, LLC	Puniska Healthcare Private Limited
water(059QF0KO0R)

Drug Product Composition: Potassium Phosphate